FDA Nod For Label Expansion Of Sutent, Egalet Flies, Double Blessing For Roche

Today's Daily Dose brings you news about Aerie's progress in phase II trial of glaucoma drug in Japan; phase III results of Egalet's pain pill; FDA approval of GlaxoSmithKline's COPD drug; expanded labeling for Pfizer's kidney cancer drug Sutent and Roche's double blessing on Thursday.

from RTT - Biotech http://ift.tt/2zHbvGp
via IFTTT